Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Go back to Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
(NASDAQ: KALA) Delayed: 0.60 +0.04 (7.14%)
Previous Close $0.56    52 Week High
Open $0.57    52 Week Low
Day High $0.61    P/E N/A 
Day Low $0.55    EPS
Volume 136,615